烧伤护理市场 - 按产品类型、烧伤深度、最终用途 - 全球预测

Burn Care Market - By Product Type, By Depth of Burn, By End-use - Global Forecast

出版日期: 2024年05月23日 | 出版商:

Global Market Insights Inc. | 英文 100 Pages | 商品交期: 2-3个工作天内

价格

简介目录

在政府支持性政策、烧伤护理研究资金以及提高烧伤治疗机会的公众意识活动的推动下，全球烧伤护理市场从 2024 年到 2032 年将呈现 7.4% 的复合年增长率。政府政策和财政支持促进了烧伤治疗技术的先进研究和开发，从而产生创新的产品和疗法。由政府资助的公众意识活动和教育计划增加了有关烧伤预防和及时治疗重要性的知识。此外，政府补贴和资金加强了医疗保健基础设施，确保更好地获得烧伤护理服务，特别是在服务不足的地区。

举个例子，2024年1月，生物治疗公司MediWound从美国国防部获得了670万美元的追加资金，用于为美国陆军提供非手术烧伤治疗。这一增加使总预算达到 1440 万美元，促进 NexoBrid 温度稳定版本的开发。 MediWound 旨在将 NexoBrid 定位为治疗院前环境中严重烧伤的主要非手术解决方案。这种创新的生物製剂旨在去除严重烧伤的焦痂，为手术方法提供了一种经济高效的替代方案，最大限度地减少了相关成本和併发症。

此类措施也促进了烧伤管理方面医疗专业人员的培训，改善患者的治疗效果并进一步推动市场成长。

整个烧伤护理市场根据产品类型、烧伤深度、最终用途和地区进行分类。

在生物製剂治疗严重烧伤的先进治疗特性和有效性的推动下，到 2032 年，生物製剂领域将占据相当大的市场份额。生物製剂为伤口癒合和组织再生提供创新的解决方案，解决传统治疗的限制。它们能够促进快速有效的康復、降低感染风险并最大限度地减少手术干预的需要，这使得它们备受追捧。此外，持续的研究和开发，加上人们对生物製剂的认识和接受度不断提高，也增强了它们的采用。政府对生物疗法的资助和监管支持进一步推动其市场需求，为复杂的烧伤护理挑战提供先进、经济高效的解决方案。

到 2032 年，诊所可能会成为烧伤护理行业的重要最终用户。他们提供先进治疗（包括伤口护理和皮肤移植）的能力推动了他们的吸引力。患者对门诊护理的偏好增加，加上烧伤发生率上升，增加了对诊所服务的需求。此外，技术进步和医疗基础设施的改善使诊所能够提供最先进的烧伤治疗。成本效益和本地护理的便利性进一步促进了诊所在烧伤护理市场中日益重要的作用。

到2032年，亚太烧伤护理市场将录得健康估值。扩大医疗基础设施和改善医疗服务的可近性提高了烧伤治疗的可用性。随着人们对烧伤预防和治疗的认识和教育不断提高，政府对烧伤护理计划的措施和资金进一步支持了市场成长。此外，该地区日益关注医疗保健设施现代化和采用创新技术，有助于更多采用先进的烧伤护理产品和服务。

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
- 欧洲其他地区
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 中东和非洲其他地区

第 9 章：公司简介

3M Company
B. Braun Melsungen AG
Cardinal Health
Coloplast
ConvaTec Inc.
DeRoyal Industries, Inc.
Hollister Incorporated
Integra LifeSciences Corporation
Johnson & Johnson
Klinion
Medline Industries, LP
MIMEDX Group, Inc.
Molnlycke Health Care AB
Safetec of America, Inc.
Smith & Nephew

简介目录

Product Code: 1857

Global Burn Care Market will exhibit 7.4% CAGR from 2024 to 2032, driven by supportive government policies, funding for burn care research, and public awareness campaigns enhancing access to burn treatment. Government policies and financial backing facilitate advanced research and development in burn treatment technologies, leading to innovative products and therapies. Public awareness campaigns and educational programs funded by governments increase knowledge about burn prevention and the importance of timely treatment. Additionally, government subsidies and funding enhance healthcare infrastructure, ensuring better accessibility to burn care services, especially in underserved areas.

Quoting an instance, In January 2024, MediWound, a biotherapeutics company, secured additional funding of $6.7 million from the US Department of Defense to facilitate its non-surgical burn treatment for the US Army. This boost raises the total budget to $14.4 million, facilitating the development of a temperature-stable version of NexoBrid. MediWound aims to position NexoBrid as the primary non-surgical solution for treating severe burns in pre-hospital environments. This innovative biologic, designed to remove eschar from severe burns, offers a cost-effective alternative to surgical methods, minimizing related costs and complications.

Such initiatives also promote training for medical professionals in burn management, improving patient outcomes and further driving market growth.

The overall burn care market is categorized based on product type, depth of burn, end-use, and region.

The biologics segment will capture a decent market share by 2032, driven by the advanced therapeutic properties and effectiveness of biologics in treating severe burns. Biologics offer innovative solutions for wound healing and tissue regeneration, addressing the limitations of traditional treatments. Their ability to promote rapid and effective recovery, reduce infection risks, and minimize the need for surgical interventions makes them highly sought after. Additionally, ongoing research and development, coupled with increasing awareness and acceptance of biologics, enhance their adoption. Government funding and regulatory support for biologic therapies further propel their market demand, offering advanced, cost-effective solutions for complex burn care challenges.

Clinics could emerge as a prominent end-user across the burn care industry by 2032. Clinics offer specialized, accessible, and patient-centered care, making them ideal for managing burn injuries. Their ability to provide advanced treatments, including wound care and skin grafts, drives their appeal. Increased patient preference for outpatient care, coupled with the rising prevalence of burn injuries, boosts demand for clinic-based services. In addition, technological advancements and improved healthcare infrastructure enable clinics to offer state-of-the-art burn treatments. Cost-effectiveness and the convenience of localized care further contribute to the growing role of clinics in the burn care market.

Asia Pacific burn care market will record a healthy valuation by 2032. Rapid urbanization and industrialization lead to increased burn injuries, driving demand for advanced burn care solutions. Expanding healthcare infrastructure and improving access to medical services enhance the availability of burn treatments. Government initiatives and funding for burn care programs, in line with rising awareness and education about burn prevention and treatment, further support market growth. Additionally, the region's growing focus on modernizing healthcare facilities and adopting innovative technologies contributes to the increased adoption of advanced burn care products and services.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising incidence of burns
  - 3.2.1.2 Advancements in burn care technologies
  - 3.2.1.3 Growing awareness and education
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Stringent regulatory requirements
3.3 Growth potential analysis
3.4 Reimbursement scenario
3.5 Regulatory landscape
3.6 Technological landscape
3.7 Future market trends
3.8 Pricing analysis
3.9 Porter's analysis
3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Advanced dressing
- 5.2.1 Alginate dressing
- 5.2.2 Collagen dressing
- 5.2.3 Hydrogel dressing
- 5.2.4 Hydrocolloid dressing
- 5.2.5 Wound contact layers
- 5.2.6 Film dressing
- 5.2.7 Foam dressing
5.3 Traditional dressing
5.4 Biologics
5.5 Other product types

Chapter 6 Market Estimates and Forecast, By Depth Of Burn, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Full thickness burns
6.3 Partial thickness burns
6.4 Minor burns

Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Hospitals
7.3 Clinics
7.4 Homecare settings
7.5 Ambulatory surgical centers (ASCs)
7.6 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa